Adrie Seldenrijk is senior researcher at the academic workplace for Anxiety Disorders of GGZ inGeest. Adrie combines clinical work, research and educational activities.
In 2011, she obtained her PhD in psychiatry with a thesis on ‘Depression, anxiety and subclinical cardiovascular disease’, mainly based on the NESDA cohort. In the past years, she has kept a special interest in the psychological and pharmacological treatment of depressive and anxiety disorders. At this moment, her main research focus lies in the optimisation of anxiety treatment via personalised medicine. She particularly is investigating the prognostic potential of acute tryptophan depletion and initial severity of symptoms on treatment outcomes.
In addition to her research, Adrie is GZ-psychologist at the academic outpatient department for e-health ‘Mindway’, and working as vice coordinator of the psychiatry programme of VUmc School of Medical Sciences.